EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Obstructive Sleep Apnea and Type 2 Diabetes

Aaron LeBlanc

Canadian Diabetes & Endocrinology Today · 2024

DOI: 10.58931/cdet.2024.2227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Diabetes & Endocrinology Today, 2024. Verfasst von Aaron LeBlanc. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obstructive sleep apnea (OSA) and type 2 diabetes (T2D) are commonly encountered diseases in clinical practice, and there appears to be a bidirectional relationship between these 2 diseases. The presence of OSA can increase the risk of developing T2D, increase the risk of micro- and macro-vascular complications, and increase the risk of mortality. Several management strategies are available that can positively impact the outcomes of patients living with co-existing T2D and OSA. Given this bidirectional relationship, the negative consequences of untreated OSA on outcomes in T2D, along with the currently available management strategies, screening for OSA in patients with T2D should be considered.

Zitieren

APA

LeBlanc, A. (2024). Obstructive Sleep Apnea and Type 2 Diabetes. Canadian Diabetes & Endocrinology Today. https://doi.org/10.58931/cdet.2024.2227

Vancouver

LeBlanc A. Obstructive Sleep Apnea and Type 2 Diabetes. Canadian Diabetes & Endocrinology Today. 2024. doi:10.58931/cdet.2024.2227

BibTeX
@article{LeBlanc2024,
  author = {LeBlanc, Aaron},
  title = {Obstructive Sleep Apnea and Type 2 Diabetes},
  journal = {Canadian Diabetes & Endocrinology Today},
  year = {2024},
  doi = {10.58931/cdet.2024.2227}
}
Kostenlos starten →